Ad5-nCoV

Mar- 2021 -

28 marzo

English

Redacción Opportimes

CanSino vaccine: 90.07% efficacy in serious diseases

CanSino Biologics Inc.‘s vaccine (Ad5-nCoV) is 90.07% effective in preventing serious illness…
Leer más »